-+ 0.00%
-+ 0.00%
-+ 0.00%

Puma Biotechnology Sees Q1 Sales $38.000M-$42.000M vs $49.000M Est

Benzinga·02/26/2026 21:06:49
Listen to the news
Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $38.000 million-$42.000 million vs $49.000 million analyst estimate.